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In Vitro Fertilization May Increase the Risk of
Beckwith-Wiedemann Syndrome Related to the
Abnormal Imprinting of the KCNQ1OT Gene
To the Editor:
“Parental imprinting” refers to an epigenetic marking of
genes that results in monoallelic expression. This phe-
nomenon plays a critical role in embryogenesis and de-
velopment. The epigenetic modification of the genome
involves methylation changes and the remodeling of
chromatin-associated proteins (Li 2002). Imprints are
established during the development of germ cells, and
the reprogramming of imprinting occurs within the first
days after fertilization (Reik and Walter 2001). The al-
teration of normal imprinting patterns is implicated in
a number of human genetic diseases. Among them, the
Beckwith-Wiedemann syndrome (BWS [MIM 130650])
is an overgrowth syndrome secondary to the dysregu-
lation of the imprinted 11p15 region (Maher and Reik
2000). Numerous mechanisms are involved in BWS, and
∼70% of cases of BWS are related to epigenetic abnor-
malities at the 11p15 locus, mostly demethylation of the
KvDMR1 region of the KCNQ1OT (previously called
“LIT1”) gene (MIM 604115) (Engel et al. 2000; Bliek
et al. 2001; Gaston et al. 2001; Weksberg et al. 2001;
DeBaun et al. 2002). KCNQ1OT encodes a noncoding
antisense transcript within intron 10 of the KCNQ1 gene
(MIM 192500) (Lee et al. 1999; Mitsuya et al. 1999;
Smilinich et al. 1999) and might be involved in the regu-
lation of parental imprinting of the centromeric domain
of the 11p15 region (Fitzpatrick et al. 2002).
In sheep and cattle, epigenetic abnormalities have been
shown to be involved in large offspring syndrome (LOS)
(Young et al. 1998). Affected animals exhibit various phe-
notypes, including large size at birth. In both species, the
syndrome is caused by the in vitro exposure of embryos,
between fertilization and the blastocyst stage, to various
unusual environments. LOS is related to the loss of im-
printing of the IGF2 receptor gene (MIM 147280), which
ensures internalization and degradation of IGF2 and dis-
plays an antiproliferative function (Young et al. 2001).
In vitro preimplantation procedures in mice are also re-
sponsible for overgrowth, owing to the abnormal ex-
pression of various imprinted genes, particularly the genes
located at distal chromosome 7 (h19 [MIM 103280] and
igf2 [MIM 147470] genes), orthologous to the human
11p15 region (Humpherys et al. 2001; Rideout et al.
2001). In humans, a case of BWS was recently described
after in vitro fertilization (IVF) (Olivennes et al. 2001).
Moreover, two recent papers (DeBaun et al. 2003;
Maher et al. 2003) described an increase in prevalence
of assisted reproductive technologies (ART) in patients
with BWS. De Baun et al. (2003) reported a sixfold
increase (4.6% vs. 0.76% in the general population)
and showed that four of the six patients for whom DNA
was available exhibited an isolated demethylation of
KvDMR1 in the KCNQ1OT gene. Maher et al. (2003)
reported a threefold increase (4% vs. 0.997% in the
general population) and demonstrated that two of the
six patients on whom molecular analysis could be done
also exhibited an isolated demethylation of KvDMR1.
Our department is a reference center in France for
molecular diagnosis of BWS, and patients are referred
from various medical departments (neonatology, pediat-
rics, genetics, and fetopathology). We studied a series of
149 patients referred for overgrowth syndromes and di-
agnosed as BWS, since all of them exhibited genetic or
epigenetic defects at the 11p15 locus. According to
the inclusion criteria described elsewhere (Gaston et al.
2001), 102 patients exhibited a complete form of BWS,
and 47 exhibited an incomplete form of BWS. The tech-
niques used to analyze the 11p15 region have been de-
scribed elsewhere (Gaston et al. 2000, 2001). Epigenetic
changes concerned 104 (70%) patients, most of whom
( ) exhibited a loss of KvDMR1 methylation.np 90
Fourteen patients (9.4%) exhibited isolated hypermethy-
lation of the H19 gene. Forty-two patients exhibited a
genetic defect: 11p15 uniparental disomy ( ;np 35
23.5%) and germline CDKN1C (MIM 600856) muta-
tion ( ; 4.7%). Three patients (2%) had a chro-np 7
mosomal abnormality.
Six of the 149 patients were born following ART. Of
note, these six patients exhibited the same epigenetic
abnormality (isolated demethylation of KvDMR1 with
a demethylation index varying 72%–100%) (fig. 1). All
of them were sporadic cases, and one was a DZ twin.
The clinical features of these patients and the procedures
of ART used for their conception are summarized in
table 1. As shown in table 1, the phenotypes of patients
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Figure 1 Methylation analysis of KvDMR1 in liver tissue (pa-
tient 131) and leukocytes (patients 15, 94, 98, 115, and 137) from
the six patients with BWS born after ART and in leukocytes from a
normal control (C). Genomic DNA was digested with BamHI and the
methylation-sensitive enzyme NotI. Digested samples were subjected
to electrophoresis in a 0.7% agarose gel, blotted onto Hybond XL
membranes, and hybridized with the HLHAY79 KvDMR1 probe cor-
responding to EST 68627 (ATCC; Manassas). The upper band (6 kb)
is methylated and corresponds to the maternal allele. The lower band
(4.2 kb) is unmethylated and corresponds to the paternal allele.
born after ART were not different from phenotypes of
the other patients ( ) with isolated demethylationnp 84
of KVDMR1, with the exception that only one patient
born after ART exhibited ear abnormalities. These chil-
dren were issued from various ART procedures: classical
IVF, intracytoplasmic sperm injection (ICSI), embryo
freezing, and transfer on day 2, day 3, and day 5. More
recent procedures, like ICSI (two of six patients) or blas-
tocyst transfer (one of six patients), did not prevail over
other techniques. The representation of ART (4%) in
our series is three times higher than that in the general
population (1.3%), according to the national report of
the French Ministry of Health (9,930 of 770,000 live
births resulting in 1,999 from IVF, ICSI, or frozen em-
bryo transfer). On the basis of this report, we would
have expected 1.94 of the 149 patients with BWS to be
born as a result of ART. To test the significance of this
difference of frequencies, we used the Fisher’s exact test
( ) as well as the Poisson approximation (two-Pp .01
tailed ; 95% CI 1.5–8.7). Strength of the as-Pp .018
sociation between exposure to ART and risk of BWS is
expressed by an odds ratio of 3.2 (95% CI 1.4–7.3).
This rate is the same as that described by Maher et al.
(2003) but lower than that described by DeBaun et al.
(2003), which addressed a prospective study. In our se-
ries and in Maher’s series, this rate is probably under-
estimated, as specific questions regarding ART have only
been asked systematically in the past year.
Although the analysis of the imprinting status at chro-
mosome 15q11-13 in children born after ICSI did not
reveal an imprinting defect (Manning et al. 2000), two
recent papers reported three patients with Angelman
syndrome (MIM 105830) born after ICSI (Cox et al.
2002; Ørstavik et al. 2002). All three patients exhibited
an imprinting defect, which is a rare cause of Angelman
syndrome.
As in the previous two reports (DeBaun et al. 2003;
Maher et al. 2003), our data suggest that ART may favor
imprinting alterations at the centromeric imprinted 11p15
locus and, consequently, the incidence of BWS. These data
highlight the need to carefully follow up children born
after ART to test for BWS and other diseases related
to imprinted regions. Although no specific procedures
of ART appear to be associated with a risk of BWS in
our series, these data lend support to the importance of
precisely recording these different procedures of ART,
particularly the stimulation protocol, the biological tech-
nique, the stage of maturation of the gametes, the cul-
ture media used at each step, and the timing of embryo
transfer.
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To Trust or Not to Trust an Idiosyncratic
Mitochondrial Data Set
To the Editor:
In a recent report, Silva et al. (2002) provided partial
(8.8 kb) information on the mtDNA coding region
(within the region 7148–15946, in the numbering of the
Cambridge reference sequence [CRS]; Anderson et al.
[1981]) in 40 individuals from Brazil. On the basis of
the similarity in nucleotide diversity and age estimates
of the four founder haplogroups A, B, C, and D, they
claimed to have added new evidence for a single early
entry of the founder populations into America. However,
a site-by-site audit of the data reveals that their sequences
are not of high enough quality to justify such statements.
The authors failed to realize that a large number of mu-
tations associated with basal branches of the worldwide
mtDNA phylogeny (Finnila¨ et al. 2001; Maca-Meyer et
al. 2001; Torroni et al. 2001; Derbeneva et al. 2002;
Herrnstadt et al. 2002; Kivisild et al. 2002) were not
correctly scored in their data set.
